Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms Bipolar Disorder Bipolar and Related Disorders Mental Disorders Mood Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 or older
Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform.
Enrolled in the MoodNetwork

Exclusion criteria

Report positively on the QIDS-SR suicide item during study intake
Total score greater than 15 on the QIDS-SR during the screening process

Treatment and study plan

Cogito Companion Mobile Phone Application

Other

Other names: Cogito Mobile Sensing Platform

Primary outcomes

Severity of MDD symptoms as assessed by QIDS SR

Time frame: 6 months
Severity of Mania symptoms as assessed by ASRM

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Cogito Health Inc

Industry

Collaborators

Massachusetts General Hospital
Partners HealthCare

Registry information

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2018
First posted: Apr 18, 2016
Registry last updated: Jul 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed